XTX Topco’s Catheter Precision VTAK Stock Holding History

XTX Topco’s Portfolio VTAK Stock Details VTAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,353	Closed	-$15.4K	–	3238
2025 Q1	$15.4K	Buy	2,353 +1,096	+87%	+$8.29K	﹤0.01%	2190
2024 Q4	$10.8K	Buy	+1,257	New	+$10.8K	﹤0.01%	2137
2024 Q3	–	Sell	-60	Closed	-$6.68K	–	2659
2024 Q2	$6.68K	Buy	+60	New	+$6.1K	﹤0.01%	1730
2022 Q1	–	Sell	-1	Closed	-$21K	–	974
2021 Q4	$21K	Buy	+1	New	+$23.8K	0.01%	626

Other funds holding VTAK

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

XTX Topco's VTAK Position: Q2 2025 in Review

XTX Topco sold out of Catheter Precision (VTAK) in Q2 2025, closing a stake of 2,353 shares — an estimated $15.4K sold.

XTX Topco first reported a position in VTAK in Q4 2021 and held it in 4 quarters. The position peaked at $21K in Q4 2021. 12 funds tracked by Wall St. Rank hold VTAK as of Q2 2025.

XTX Topco reported no remaining Catheter Precision position as of Q2 2025 after selling out during the quarter.
XTX Topco sold 2,353 Catheter Precision shares in Q2 2025, an estimated $15.4K.
XTX Topco first reported a position in Catheter Precision in Q4 2021 and held it in 4 quarters.
XTX Topco's Catheter Precision position peaked at $21K in Q4 2021.
12 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.